Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
26.33 EUR
0.34%
Market Closed
Updated:
Apr 20, 2024
Bayer AG
Cash from Operating Activities
Last
Value
3-Years CAGR
5-Years CAGR
|
Bayer AG
Cash from Operating Activities Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Cash from Operating Activities
€5.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Cash from Operating Activities
$-84.1m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Cash from Operating Activities
€3.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Cash from Operating Activities
€12m
|
CAGR 3-Years
56%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Cash from Operating Activities
€218.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Cash from Operating Activities
€24.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Cash from Operating Activities?
Cash from Operating Activities
5.1B
EUR
5.1B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Cash from Operating Activities amounts to 5.1B EUR.
What is Bayer AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
0%
0%
Over the last year, the Cash from Operating Activities growth was -28%. The average annual Cash from Operating Activities growth rates for Bayer AG have been 1% over the past three years , -8% over the past five years .
You don't have any saved screeners yet
